Efficacy and safety of 1.5% levofloxacin otic solution for the treatment of otitis media in a multicenter, randomized, double-blind, parallel-group, placebo-controlled, phase III study.
暂无分享,去创建一个
S. Iwasaki | Haruo Takahashi | S. Kariya | Masahiro Takahashi | Toshiro Kawano | R. Ikoma | Hiroaki Sato | M. Terasaki | Shigeru Oka
[1] J. Killian,et al. Benzalkonium Chloride: A Known Irritant and Novel Allergen , 2016, Dermatitis : contact, atopic, occupational, drug.
[2] T. Most,et al. Risk factors for sensorineural hearing loss in chronic otitis media , 2013, Acta oto-laryngologica.
[3] C. Gamble,et al. Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial , 2005, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[4] Į. Kaygusuz,et al. [Efficacy of topical ciprofloxacin and tobramycin in combination with dexamethasone in the treatment of chronic suppurative otitis media]. , 2002, Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat.
[5] W. Craig. Does the dose matter? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] L. Kasemsuwan,et al. A double blind, prospective trial of topical ciprofloxacin versus normal saline solution in the treatment of otorrhoea. , 1997, Clinical otolaryngology and allied sciences.
[7] A. Koc,et al. Treatment of chronic ear disease. Topical ciprofloxacin vs topical gentamicin. , 1995, Archives of otolaryngology--head & neck surgery.
[8] T. Nishino,et al. In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin. , 1990, The Journal of antimicrobial chemotherapy.
[9] S. Esposito,et al. Topical and oral treatment of chronic otitis media with ciprofloxacin. A preliminary study. , 1990, Archives of otolaryngology--head & neck surgery.
[10] T. Une,et al. In vitro activity of DR-3355, an optically active ofloxacin , 1988, Antimicrobial Agents and Chemotherapy.
[11] I. Hayakawa,et al. Synthesis and antibacterial activities of optically active ofloxacin , 1986, Antimicrobial Agents and Chemotherapy.
[12] Hisashi Takahashi,et al. [The history of the development and changes of quinolone antibacterial agents]. , 2003, Yakushigaku zasshi.
[13] Á. Ramos,et al. Utilización del ciprofloxacino tópico en la otitis media crónica supurada , 2003 .
[14] O. Nawasreh,et al. Topical ciprofloxacin versus topical gentamicin for chronic otitis media. , 2001, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[15] Á. Ramos Macias,et al. [Antimicrobial therapy in chronic suppurative otitis media]. , 1999, Acta otorrinolaringologica espanola.
[16] J. Viñas,et al. [Multicenter study comparing the efficacy and tolerance of topical ciprofloxacin (0.3%) versus topical gentamicin (0.3%) in the treatment of simple, non-cholesteatomaous chronic otitis media in the suppurative phase]. , 1995, Anales otorrinolaringologicos ibero-americanos.